BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37922952)

  • 1. Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ß-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association With Endometrioid Type II Stem Cell Outgrowths in the Fallopian Tube.
    Xu J; McGregor SM; Park KJ; Weisman PS
    Int J Gynecol Pathol; 2024 Mar; 43(2):145-148. PubMed ID: 37922952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
    Brouwer J; Strickland KC; Ning G; Schmelkin CB; Kolin DL; Hecht J; Nucci MR; Mourits MJ; Xian W; Crum CP
    Int J Gynecol Pathol; 2020 Mar; 39(2):163-169. PubMed ID: 31574529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrioid Tubal Intraepithelial Neoplasia (E-TIN) of the Fallopian Tube: A Case Series.
    Hecht JL; Lin DI; Garrett L
    Int J Gynecol Pathol; 2020 Nov; 39(6):552-557. PubMed ID: 31855954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
    de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
    Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
    Lu H; Allende D; Liu X; Zhang Y
    Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma.
    Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model for endometrioid ovarian cancer arising from the distal oviduct.
    van der Horst PH; van der Zee M; Heijmans-Antonissen C; Jia Y; DeMayo FJ; Lydon JP; van Deurzen CH; Ewing PC; Burger CW; Blok LJ
    Int J Cancer; 2014 Sep; 135(5):1028-37. PubMed ID: 24474556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm.
    Aldaoud N; Erashdi M; AlKhatib S; Abdo N; Al-Mohtaseb A; Graboski-Bauer A
    BMC Res Notes; 2019 Nov; 12(1):770. PubMed ID: 31771640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of WT1 and PAX8 in the epithelial tumours of Malaysian women with ovarian cancer.
    Rhodes A; Vallikkannu N; Jayalakshmi P
    Br J Biomed Sci; 2017 Apr; 74(2):65-70. PubMed ID: 28367736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
    Weisman P; Park KJ; Xu J
    Int J Gynecol Pathol; 2022 Mar; 41(2):126-131. PubMed ID: 33811207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrioid ciliated-cell tumors of the ovary: a report of five cases.
    Eichhorn JH; Scully RE
    Int J Gynecol Pathol; 1996 Jul; 15(3):248-56. PubMed ID: 8811387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.
    Ates Ozdemir D; Usubutun A
    Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.
    Houghton O; Connolly LE; McCluggage WG
    Histopathology; 2008 Aug; 53(2):156-65. PubMed ID: 18752499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.
    Wang L; Rambau PF; Kelemen LE; Anglesio MS; Leung S; Talhouk A; Köbel M
    Histopathology; 2019 Feb; 74(3):452-462. PubMed ID: 30326146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.
    Chaves-Moreira D; Mitchell MA; Arruza C; Rawat P; Sidoli S; Nameki R; Reddy J; Corona RI; Afeyan LK; Klein IA; Ma S; Winterhoff B; Konecny GE; Garcia BA; Brady DC; Lawrenson K; Morin PJ; Drapkin R
    Sci Signal; 2022 Apr; 15(728):eabm2496. PubMed ID: 35380877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of the Fallopian Tube: Tubal Involvement by Ovarian Tumors and Incidental Findings in the Nontumoral Setting.
    Karpathiou G; Chauleur C; Venet M; Clemenson A; Peoc'h M
    Pathobiology; 2020; 87(1):37-44. PubMed ID: 31972564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory role of prohibitin in human ovarian epithelial cancer.
    Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX
    Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma.
    Bossuyt V; Medeiros F; Drapkin R; Folkins AK; Crum CP; Nucci MR
    Int J Gynecol Pathol; 2008 Jul; 27(3):390-7. PubMed ID: 18580316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.